Abstract
COVID-19 has had an unprecedented worldwide impact, and Peru has had one of the highest COVID-19 case rates despite implementation of an early strict nationwide quarantine. Repercussions on Peru’s healthcare system may impact vulnerable populations, particularly people with HIV (PWH). We explored the knowledge of COVID-19 and the socioeconomic and health impact of the pandemic among middle-aged and older PWH. A cross-sectional telephone survey was administered to 156 PWH age ≥40 years receiving care in one of two large HIV clinics in Lima, Peru. The majority of PWH (age 52±7.7 years, 41% female, 65% completed secondary school or less) were knowledgeable regarding COVID-19 symptoms and prevention methods. Nearly half of those employed prior to the pandemic reported job loss. Female sex (unadjusted prevalence ratio [PR] 1.85 [95%CI 1.27-2.69]), low educational level (PR 1.62 [1.06-2.48]) and informal work (PR 1.58 [1.06-2.36]) were risk factors for unemployment but not in adjusted models. Increased anxiety was reported in 64% and stress in 77%. COVID-19 has had a substantial socioeconomic and mental health impact on PWH living in Lima, Peru, particularly those with lower educational levels and informal workers. Efforts are needed to ensure continued medical care and socioeconomic support of PWH in Peru.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr. Monica M. Diaz serves as a Fogarty Global Health Trainee and is supported by the FIC at the NIH under grant number D43TW009343 and is also supported by the Alzheimers Disease Resource Center for advancing Minority Aging Research at the University of California San Diego (P30AG059299, National Institute on Aging). Dr. Diego M. Cabrera serves as a Fogarty Global Health Trainee and is supported by the Fogarty International Center (FIC) at the National Institutes of Health (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under grant number D43TW010540. Dr. Hsieh is supported by NIH/Fogarty International Center K01TW009995. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and approved by the ethics committees of the Yale School of Medicine and Universidad Peruana Cayetano Heredia. All participants provided verbal informed consent after a comprehensive explanation of the procedures by phone prior to study enrollment.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: Dr. Monica M. Diaz serves as a Fogarty Global Health Trainee and is supported by the FIC at the NIH under grant number D43TW009343 and is also supported by the Alzheimer’s Disease Resource Center for advancing Minority Aging Research at the University of California San Diego (P30AG059299, National Institute on Aging). Dr. Diego M. Cabrera serves as a Fogarty Global Health Trainee and is supported by the Fogarty International Center (FIC) at the National Institutes of Health (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under grant number D43TW010540. Dr. Hsieh is supported by NIH/Fogarty International Center K01TW009995. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Disclosures: MMD has no disclosures to report. DMC has no disclosures to report. MG has no disclosures to report. VR has no disclosures to report. MS has no disclosures to report. PJG has no disclosures to report. EH has no disclosures to report.
Co-Author Contact Information: Monica M. Diaz: University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; monica.diaz{at}neurology.unc.edu
Diego M. Cabrera: Yale School of Public Health, Yale University, New Haven, Connecticut, USA; diego.cabrera{at}yale.edu
Marcela Gil-Zacarías: Universidad Peruana Cayetano Heredia, Lima, Peru; MARCELA.GIL.Z{at}upch.pe
Valeria Ramírez: Universidad Peruana Cayetano Heredia, Lima, Peru; valeria.ramirez.c{at}upch.pe
Manuel Saavedra: Universidad Peruana Cayetano Heredia, Lima, Peru; manuel.saavedra.t{at}upch.pe
Cesar Cárcamo: Universidad Peruana Cayetano Heredia, Lima, Peru; cesar.carcamo{at}upch.pe
Evelyn Hsieh: Yale School of Medicine, Yale University, New Haven, Connecticut, USA; evelyn.hsieh{at}yale.edu
Patricia J. Garcia: Universidad Peruana Cayetano Heredia, Lima, Peru; patricia.garcia{at}upch.pe
Data Availability
Data may be requested from the corresponding author.
